Blog

Antibody-mediated autoimmune encephalitis (AE) denotes a set of immune-mediated, inflammatory central nervous system (CNS) disorders linked etiologically with neuronal autoantibodies. Early use of immunotherapy in AE, especially in those associated with neuronal cell surface antibodies, without an underlying malignancy is associated with excellent outcomes [1]. A pivotal investigation in diagnosis of AE, Electroencephalography (EEG) is very sensitive in demonstrating underlying nonconvulsive status epilepticus, generalized or focal slowing with epileptiform discharges in the early stages of the disease in nearly half of the patients.